VASA Therapeutics Pre-Clinical Development

Budget

US$525,925

Lay Abstract

Project Timeline:

6 Months

Investigator:

VASA Therapeutics

Lay abstract

VASA has developed a compound that has proven successful in regenerating muscle in FSHD mice.

This funding covers the next step in getting VASA’s compound into clinic for FSHD patients.